SUGAR LAND, TX -- (Marketwire) -- 01/11/10 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Three deals dominated the drug industry this year: Each of the companies were seeking science, or more specifically, the profitable results of that science. Pfizer Incorporated (NYSE:PFE) (New York, New York) closed its $68 billion deal to purchase Wyeth. Roche Holding Limited (OTC:RHHBY) (Basel, Switzerland) finalized its nearly $47 billion move to acquire the remainder of biotech giant Genentech and Merck & Company Incorporated (NYSE:MRK) snapped up Schering-Plough for $41 billion. The dollar numbers involved are staggering, especially in the face of the global recession. But then again, this is an industry known for its deep pockets, no matter what the economic weather.
For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=154397, or browse other breaking industrial news stories at www.industrialinfo.com.
Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy related markets. For more than 26 years, Industrial Info has provided plant and project opportunity databases, market forecasts, high resolution maps, and daily industry news. For more information send inquiries to email@example.com or visit us at www.industrialinfo.com.